Mentara Bio

Durham, United States

Mentara Bio develops neurocircuit-targeting therapies and conducts clinical research for neurological disorders such as epilepsy.

$4.1M raised

Mar 2023

Series A

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mentara Bio

How much funding has Mentara Bio raised?

Mentara Bio has raised $4.1M in total funding. The most recent round was Series A. The last funding was announced in March 2023.

Where is Mentara Bio headquartered?

Mentara Bio is headquartered in Durham, United States.

What does Mentara Bio do?

Mentara Bio develops neurocircuit-targeting therapies and conducts clinical research for neurological disorders such as epilepsy.

What stage is Mentara Bio at?

Mentara Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 6, 2023.

MLA

"Mentara Bio — Funding & Investors." VCBacked, March 6, 2023, https://www.vcbacked.co/company/mentara-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). Mentara Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mentara-bio

Wikipedia (cite web)

{{cite web |title=Mentara Bio — Funding & Investors |url=https://www.vcbacked.co/company/mentara-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 6, 2023.